Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.
In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.
$374.75 3.22 (0.87)%
Market Cap 39.55B
01/22/18 3:09 PM ET | Minimum 20 minutes delay.
Stock information provided by eSignal.
36th Annual J.P. Morgan Healthcare Conference Q&A
Jan 8, 2018 | 12:00 PM PT
36th Annual J.P. Morgan Healthcare Conference
Jan 8, 2018 | 11:30 AM PT